@eden_elii: Based on true story! @RIDE Family 🎥@አኩፋዳ Digital marketing #ethiopian_tik_tok🇪🇹🇪🇹🇪🇹🇪🇹 #fyp #eduna

eduna🥀
eduna🥀
Open In TikTok:
Region: ET
Wednesday 22 October 2025 11:25:22 GMT
269456
17145
91
1135

Music

Download

Comments

user8162560665785
Dimple :
ያዙት😅😅
2025-10-22 14:29:41
581
brezzey990
ELAMAN :
ልደውልላት ነው😁
2025-10-22 15:10:47
214
_ibrobaba_
Ibrahim Mohammed :
ከሴቶች በመራቅ ጤናዎትን እና ገንዘቦን ይጠብቁ 😁🤭🙌
2025-10-22 14:08:59
52
misha_designa
misha design :
የመክናህን ዋጋ ሳትመልስ ታረጃለህ
2025-10-22 15:08:18
89
helenke0
Helen :
ዛሬ ጥቅምት 12 ነው😁
2025-10-22 12:20:50
10
manta_sdi______
Gracy :
በዚህ መኪና ራይድ አይሰራም😭😭😭
2025-10-22 18:03:44
21
beba.royal
beba royal :
ቀረፃ ባይሆን ገብታ ነበር😁
2025-10-23 10:36:54
2
wandetarekegn
Wande 21 :
ሚሊዮን አውጥቴ ልመና ድርጅት ነው ምከብርበት
2025-10-23 10:40:59
1
medu5713
መዲ✨ :
ህዳር 5 ልደቴ ነው🎂
2025-10-22 14:18:31
2
tkurfestal0
Beri👸👏 :
ልጁ ግን ውበቱ 😂😂✌
2025-10-22 14:51:16
6
fikirermias475
fikirermias :
የነካሽው ሁሉ የሚያምርልሽ ድንቅ ልጅ !!!❤❤
2025-10-22 11:36:12
22
ababie588
$amrisha19 :
ግርጣት 😂
2025-10-22 15:27:10
1
isac0528
isac :
ሴቶች አታበላሺ ግቢ በቂ ነው ከመች ጀምሮ ነው አልገባም ያሉት
2025-10-23 09:45:05
0
simx404
@SIM-X :
ታርጋ አታይም ካላሳያት ደግሞ ብትናገር ማስታወቂያው የተሟላ ይሆን ነበር
2025-10-23 08:20:41
0
nhatty_29
Nhatty e :
አይ እኔ ባለ ቁላው ነኝ🤣😂😀
2025-10-23 05:43:52
0
npc8604
sura :
4mil awutiche ride aliseram ye amiro ediget wusininet kelelebgn 😎😂
2025-10-23 02:31:25
2
ekuti131
Ekuti 🧕🧕🍫🍫 :
Kahadu aykar bazi nw enji👌
2025-10-22 14:09:38
2
lji.hani
ህያብ💅💅⁺ :
copy Link አርጉላት ፍቅሮቼ🥰🥰🔥
2025-10-22 13:52:13
1
enu_24_
ENU 24💃 :
:አርባ ሽንሽን ቀሚስ ግዙልኝ😍🤭
2025-10-23 12:20:12
0
zendeo89
@አ@#1221 ✍️✍️✍️ :
ቀሚስሺ ተቀዷል ልንገርሽ ብዬ ነዉ🤣🤣
2025-10-23 06:50:21
0
hdirknfjxidkebejdjdjehrh
xxx♓ :
አይ አሱ ነው ባሌ..... ላው
2025-10-23 06:09:40
0
dubaibahrainagent1
Dubai ,Bahrain ,Beirut :
በድዛየር ዋጋ እኮ ነው 😏
2025-10-22 20:16:54
0
abelo5900
Abelo (ፌመሱ)🏘 ቤቶች ደላላ🏘🏘 :
ሰቀጠጣት እኮ
2025-10-23 03:18:58
0
hingabu16
አውሮራ :
30 ብር የምትዘርፉንስ
2025-10-22 16:52:58
2
aljll1
@%%b :
እኔ ሁሉም ygetmegal
2025-10-22 15:06:51
0
To see more videos from user @eden_elii, please go to the Tikwm homepage.

Other Videos

Latent autoimmune diabetes in adults (LADA), also known as type 1.5 diabetes, is a slowly progressive autoimmune form of diabetes that begins in adulthood and is mistaken for type 2 diabetes. Like type 1 diabetes, the body's immune system slowly damages insulin-producing cells in the pancreas. However, unlike type 1, LADA progresses slower, and insulin is not required immediately after diagnosis.  Characteristics of LADA Adult Onset: It typically appears in individuals over 30 years old.  Autoimmune Process: The body's immune system attacks the insulin-producing beta cells in the pancreas.  Slow Progression: The progression toward absolute insulin dependency is slower than in typical type 1 diabetes.  Misdiagnosis: Because of its slow onset and initial non-insulin-requiring nature, it is often misdiagnosed as type 2 diabetes.  Presence of Autoantibodies: Diagnosis is supported by the presence of islet autoantibodies (e.g., GAD antibodies) in the blood.  Healthy Weight: People with LADA tend to be of a healthy weight at diagnosis, unlike many with type 2 diabetes who are overweight or obese.  Treatment and Management Focus on Beta-Cell Protection: Treatment aims to preserve the remaining insulin-producing cells to slow disease progression.  Insulin Therapy: Although not always required immediately, insulin is the eventual treatment of choice for LADA patients as beta-cell function declines.  Other Medications: Some treatments may include medications used for type 2 diabetes, such as Metformin or SGLT2 inhibitors, to help manage blood sugar levels.  Monitoring: Regular monitoring of blood glucose levels is necessary, even if insulin is not initially prescribed.  Distinguishing LADA from Type 2 Diabetes Autoimmune vs. Lifestyle: LADA is an autoimmune condition, whereas type 2 diabetes is not immune-mediated.  Weight Status: LADA patients are typically not overweight or obese, which is a common characteristic of type 2 diabetes.  Antibodies: LADA is confirmed by the presence of autoantibodies, which are absent in type 2 diabetes.
Latent autoimmune diabetes in adults (LADA), also known as type 1.5 diabetes, is a slowly progressive autoimmune form of diabetes that begins in adulthood and is mistaken for type 2 diabetes. Like type 1 diabetes, the body's immune system slowly damages insulin-producing cells in the pancreas. However, unlike type 1, LADA progresses slower, and insulin is not required immediately after diagnosis. Characteristics of LADA Adult Onset: It typically appears in individuals over 30 years old. Autoimmune Process: The body's immune system attacks the insulin-producing beta cells in the pancreas. Slow Progression: The progression toward absolute insulin dependency is slower than in typical type 1 diabetes. Misdiagnosis: Because of its slow onset and initial non-insulin-requiring nature, it is often misdiagnosed as type 2 diabetes. Presence of Autoantibodies: Diagnosis is supported by the presence of islet autoantibodies (e.g., GAD antibodies) in the blood. Healthy Weight: People with LADA tend to be of a healthy weight at diagnosis, unlike many with type 2 diabetes who are overweight or obese. Treatment and Management Focus on Beta-Cell Protection: Treatment aims to preserve the remaining insulin-producing cells to slow disease progression. Insulin Therapy: Although not always required immediately, insulin is the eventual treatment of choice for LADA patients as beta-cell function declines. Other Medications: Some treatments may include medications used for type 2 diabetes, such as Metformin or SGLT2 inhibitors, to help manage blood sugar levels. Monitoring: Regular monitoring of blood glucose levels is necessary, even if insulin is not initially prescribed. Distinguishing LADA from Type 2 Diabetes Autoimmune vs. Lifestyle: LADA is an autoimmune condition, whereas type 2 diabetes is not immune-mediated. Weight Status: LADA patients are typically not overweight or obese, which is a common characteristic of type 2 diabetes. Antibodies: LADA is confirmed by the presence of autoantibodies, which are absent in type 2 diabetes.

About